These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 20686114)

  • 1. Imaging decreased brain docosahexaenoic acid metabolism and signaling in iPLA(2)β (VIA)-deficient mice.
    Basselin M; Rosa AO; Ramadan E; Cheon Y; Chang L; Chen M; Greenstein D; Wohltmann M; Turk J; Rapoport SI
    J Lipid Res; 2010 Nov; 51(11):3166-73. PubMed ID: 20686114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disturbed brain phospholipid and docosahexaenoic acid metabolism in calcium-independent phospholipase A(2)-VIA (iPLA(2)β)-knockout mice.
    Cheon Y; Kim HW; Igarashi M; Modi HR; Chang L; Ma K; Greenstein D; Wohltmann M; Turk J; Rapoport SI; Taha AY
    Biochim Biophys Acta; 2012 Sep; 1821(9):1278-86. PubMed ID: 22349267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular-derived calcium does not initiate in vivo neurotransmission involving docosahexaenoic acid.
    Ramadan E; Rosa AO; Chang L; Chen M; Rapoport SI; Basselin M
    J Lipid Res; 2010 Aug; 51(8):2334-40. PubMed ID: 20388940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docosahexaenoic acid (DHA) incorporation into the brain from plasma, as an in vivo biomarker of brain DHA metabolism and neurotransmission.
    Rapoport SI; Ramadan E; Basselin M
    Prostaglandins Other Lipid Mediat; 2011 Nov; 96(1-4):109-13. PubMed ID: 21704722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Docosahexaenoic acid and arachidonic acid release in rat brain astrocytes is mediated by two separate isoforms of phospholipase A2 and is differently regulated by cyclic AMP and Ca2+.
    Strokin M; Sergeeva M; Reiser G
    Br J Pharmacol; 2003 Jul; 139(5):1014-22. PubMed ID: 12839876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D2-like receptor activation does not initiate a brain docosahexaenoic acid signal in unanesthetized rats.
    Taha AY; Chang L; Chen M; Rapoport SI; Ramadan E
    BMC Neurosci; 2014 Oct; 15():113. PubMed ID: 25359512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resting and arecoline-stimulated brain metabolism and signaling involving arachidonic acid are altered in the cyclooxygenase-2 knockout mouse.
    Basselin M; Villacreses NE; Langenbach R; Ma K; Bell JM; Rapoport SI
    J Neurochem; 2006 Feb; 96(3):669-79. PubMed ID: 16405503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for the involvement of docosahexaenoic acid in cholinergic stimulated signal transduction at the synapse.
    Jones CR; Arai T; Rapoport SI
    Neurochem Res; 1997 Jun; 22(6):663-70. PubMed ID: 9178948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging brain signal transduction and metabolism via arachidonic and docosahexaenoic acid in animals and humans.
    Basselin M; Ramadan E; Rapoport SI
    Brain Res Bull; 2012 Feb; 87(2-3):154-71. PubMed ID: 22178644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flurbiprofen, a cyclooxygenase inhibitor, reduces the brain arachidonic acid signal in response to the cholinergic muscarinic agonist, arecoline, in awake rats.
    Basselin M; Villacreses NE; Lee HJ; Bell JM; Rapoport SI
    Neurochem Res; 2007 Nov; 32(11):1857-67. PubMed ID: 17562170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arachidonic acid and the brain.
    Rapoport SI
    J Nutr; 2008 Dec; 138(12):2515-20. PubMed ID: 19022981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docosahexaenoic acid (DHA): An essential nutrient and a nutraceutical for brain health and diseases.
    Sun GY; Simonyi A; Fritsche KL; Chuang DY; Hannink M; Gu Z; Greenlief CM; Yao JK; Lee JC; Beversdorf DQ
    Prostaglandins Leukot Essent Fatty Acids; 2018 Sep; 136():3-13. PubMed ID: 28314621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PLA2G6 mutations cause motor dysfunction phenotypes of young-onset dystonia-parkinsonism type 14 and can be relieved by DHA treatment in animal models.
    Yeh TH; Liu HF; Chiu CC; Cheng ML; Huang GJ; Huang YC; Liu YC; Huang YZ; Lu CS; Chen YC; Chen HY; Cheng YC
    Exp Neurol; 2021 Dec; 346():113863. PubMed ID: 34520727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Threshold changes in rat brain docosahexaenoic acid incorporation and concentration following graded reductions in dietary alpha-linolenic acid.
    Taha AY; Chang L; Chen M
    Prostaglandins Leukot Essent Fatty Acids; 2016 Feb; 105():26-34. PubMed ID: 26869088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroaxonal dystrophy in calcium-independent phospholipase A2β deficiency results from insufficient remodeling and degeneration of mitochondrial and presynaptic membranes.
    Beck G; Sugiura Y; Shinzawa K; Kato S; Setou M; Tsujimoto Y; Sakoda S; Sumi-Akamaru H
    J Neurosci; 2011 Aug; 31(31):11411-20. PubMed ID: 21813701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disrupted membrane homeostasis and accumulation of ubiquitinated proteins in a mouse model of infantile neuroaxonal dystrophy caused by PLA2G6 mutations.
    Malik I; Turk J; Mancuso DJ; Montier L; Wohltmann M; Wozniak DF; Schmidt RE; Gross RW; Kotzbauer PT
    Am J Pathol; 2008 Feb; 172(2):406-16. PubMed ID: 18202189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catalytic function of PLA2G6 is impaired by mutations associated with infantile neuroaxonal dystrophy but not dystonia-parkinsonism.
    Engel LA; Jing Z; O'Brien DE; Sun M; Kotzbauer PT
    PLoS One; 2010 Sep; 5(9):e12897. PubMed ID: 20886109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. iPLA2β knockout mouse, a genetic model for progressive human motor disorders, develops age-related neuropathology.
    Blanchard H; Taha AY; Cheon Y; Kim HW; Turk J; Rapoport SI
    Neurochem Res; 2014 Aug; 39(8):1522-32. PubMed ID: 24919816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rat brain docosahexaenoic acid metabolism is not altered by a 6-day intracerebral ventricular infusion of bacterial lipopolysaccharide.
    Rosenberger TA; Villacreses NE; Weis MT; Rapoport SI
    Neurochem Int; 2010 Feb; 56(3):501-7. PubMed ID: 20026368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain arachidonic and docosahexaenoic acid cascades are selectively altered by drugs, diet and disease.
    Rapoport SI
    Prostaglandins Leukot Essent Fatty Acids; 2008; 79(3-5):153-6. PubMed ID: 18973997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.